About this medical device
Status Prototyped
Made? No
Replicated? No
Designed in Australia
Replicated in Africa, Asia, South America
Health topic Maternal mortality
Health classification Preventative
Documentation data
License data
Hardware CC BY-SA 4.0

Problem being addressed[edit | edit source]

Women in developing nations often do not have access to contraceptives, and in the case that they do, may find it difficult to adhere to tedious guidelines on a regular basis. Essentially, there is a need for easy-to-use, cost-effective contraceptives that do not require regular maintenance or effort.

Detailed description of the solution[edit | edit source]

This innovative drug delivery system is a subcutaneous biosynthetic bone-like material made of calcium minerals that, once implanted, can deliver contraceptives at regular intervals in a sustained manner for several months.

Designed by[edit | edit source]

  • Designed by: This device is currently being developed by Gérrard Poinern of Murdoch University in Australia.
  • Manufacturer location: Murdoch University in Perth, Australia

When and where it was tested/implemented[edit | edit source]

A research group is currently developing the technology to be feasible, and if successful, will collaborate with a drug company to begin human trials.

Funding Source[edit | edit source]

This device received funding from the Grand Challenges Exploration Grant from the Bill & Melinda Gates Foundation.

References[edit | edit source]

Other internally generated reports[edit | edit source]

Murdoch receives $100,000 to develop a contraceptive for third world. (2010, November 10). Murdoch University. Retrieved February 5, 2013. Link available here.

Externally generated reports[edit | edit source]

Grand Challenges Explorations: Round 5 Winners Highlights. (n.d.). Bill & Melinda Gates Foundation. Retrieved February 5, 2013. Link available here.